Johnson RJ - Search Results

1

Hormonal and cytokine effects of uric acid.

Sánchez-Lozada LG, Nakagawa T, Kang DH, Feig DI, Franco M, Johnson RJ, Herrera-Acosta J. Sánchez-Lozada LG, et al. Among authors: johnson rj. Curr Opin Nephrol Hypertens. 2006 Jan;15(1):30-3. doi: 10.1097/01.mnh.0000199010.33929.7f. Curr Opin Nephrol Hypertens. 2006. PMID: 16340663 Review.

2

A new model of renal microvascular injury.

Nangaku M, Shankland SJ, Couser WG, Johnson RJ. Nangaku M, et al. Among authors: johnson rj. Curr Opin Nephrol Hypertens. 1998 Jul;7(4):457-62. doi: 10.1097/00041552-199807000-00018. Curr Opin Nephrol Hypertens. 1998. PMID: 9690047 Review.

3

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.

Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Kim YG, et al. Among authors: johnson rj. Kidney Int. 2000 Dec;58(6):2390-9. doi: 10.1046/j.1523-1755.2000.00422.x. Kidney Int. 2000. PMID: 11115072 Free article.

4

Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.

Kim YG, Huang XR, Suga S, Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson RJ, Lan HY. Kim YG, et al. Among authors: johnson rj. Mol Med. 2000 Oct;6(10):837-48. Mol Med. 2000. PMID: 11126199 Free PMC article.

5

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. Am J Kidney Dis. 2001 Mar;37(3):601-11. doi: 10.1053/ajkd.2001.22087. Am J Kidney Dis. 2001. PMID: 11228186

6

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.

Kang DH, Kim YG, Andoh TF, Gordon KL, Suga S, Mazzali M, Jefferson JA, Hughes J, Bennett W, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. Am J Physiol Renal Physiol. 2001 Apr;280(4):F727-36. doi: 10.1152/ajprenal.2001.280.4.F727. Am J Physiol Renal Physiol. 2001. PMID: 11249864 Free article.

7

Role of immunocompetent cells in nonimmune renal diseases.

Rodríguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. Rodríguez-Iturbe B, et al. Among authors: johnson rj. Kidney Int. 2001 May;59(5):1626-40. doi: 10.1046/j.1523-1755.2001.0590051626.x. Kidney Int. 2001. PMID: 11318933 Free article. Review.

8

Hyperuricemia exacerbates chronic cyclosporine nephropathy.

Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ. Mazzali M, et al. Among authors: johnson rj. Transplantation. 2001 Apr 15;71(7):900-5. doi: 10.1097/00007890-200104150-00014. Transplantation. 2001. PMID: 11349724

9

Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. J Am Soc Nephrol. 2001 Jul;12(7):1434-1447. doi: 10.1681/ASN.V1271434. J Am Soc Nephrol. 2001. PMID: 11423572

10

Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. J Am Soc Nephrol. 2001 Jul;12(7):1448-1457. doi: 10.1681/ASN.V1271448. J Am Soc Nephrol. 2001. PMID: 11423573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,489 results

Search Page

Filters